Esperion Therapeutics Stock Discussion

$Esperion Therapeutics (ESPR.US)$ need to increase my holding for a decent Xmas meal….maybe next year

$Esperion Therapeutics (ESPR.US)$
Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024
Esperion (ESPR) presented new exploratory data from the CLEAR Outcomes trial at the 2024 AHA Scientific Sessions, highlighting significant benefits of NEXLETOL (bempedoic acid).
The analysis showed patients with Peripheral Artery Disease (PAD) tak...

This $2 Stock Remains Deeply Undervalued, Profitable in 2025, Offers 10x Upside within 20 Months
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns   $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.  
This unique biotech     $Esperion Therapeutics (ESPR.US)$  Esper...

$Esperion Therapeutics (ESPR.US)$  this zone level 2.600 possibility price reject. due to high volume

$Esperion Therapeutics (ESPR.US)$ $10 …. 🚀🚀🚀

$Esperion Therapeutics (ESPR.US)$ we go upupupppp !!!!